NEI Research News

Imagine you are building a house. You would need a team of specialists, including an architect, a general contractor, carpenters, an electrician, a plumber and many others.

Researchers are making progress toward understanding how some cases of glaucoma begin.

Most Americans do not know the risks and warning signs of diseases that could blind them if they don’t seek timely detection and treatment.

Glaucoma is an eye disease usually associated with an increased fluid pressure inside the eyes that damages the optic nerve, leading to vision loss or even blindness.

Eye drops that reduce elevated pressure inside the eye can delay or possibly prevent the onset of glaucoma in African Americans at higher risk for developing the disease, researchers have found.

Researchers have found that immediately treating people who have early stage glaucoma can delay progression of the disease.

Researchers have discovered that eye drops used to treat elevated pressure inside the eye can be effective in delaying the onset of glaucoma.

Glaucoma is one of the most common causes of visual loss in the United States and affects about three million Americans. A standard medical treatment for newly diagnosed glaucoma is using eye drops and/or laser treatment to lower the pressure inside...

In a small preliminary study, researchers at the National Institutes of Health (NIH) have discovered a possible new treatment for uveitis, a potentially blinding eye disease.

Researchers supported by the National Institutes of Health have discovered that black and white patients with advanced glaucoma respond differently to two surgical treatments for the disease. A paper detailing these findings is published in the July 1998